Literature DB >> 9746573

Differential normalization of mucosal interleukin-8 and interleukin-6 activity after Helicobacter pylori eradication.

T Ando1, K Kusugami, M Ohsuga, K Ina, M Shinoda, T Konagaya, T Sakai, A Imada, N Kasuga, T Nada, S Ichiyama, M J Blaser.   

Abstract

There is differential resolution of mucosal infiltration with neutrophils and mononuclear cells following successful Helicobacter pylori eradication. We investigated the effects of H. pylori eradication on mucosal interleukin-8 (IL-8) and IL-6 activity in relation to the resolution of H. pylori-associated gastritis. Eighty-one duodenal ulcer patients with H. pylori infection received dual- or triple-treatment eradication therapy, and mucosal biopsy specimens obtained at the initial and follow-up endoscopic examinations were cultured in vitro for 24 h. The levels of IL-8 and IL-6 were measured by enzyme-linked immunosorbent assays. In the 42 patients in whom H. pylori eradication failed, there was little change in the numbers of neutrophils and mononuclear cells infiltrating the mucosa and in IL-8 and IL-6 activity. In the 39 patients in whom H. pylori was eradicated, there was normalization both in the numbers of infiltrating neutrophils and in mucosal IL-8 activity, which was evident within 1 month following therapy. In contrast, there was a gradual resolution of mononuclear cell infiltration over a 6-month period, accompanied by a gradual normalization in IL-6 levels. Addition of H. pylori to cultures of mucosal tissues induced a significant increase in IL-8 activity in both uninfected control subjects and patients from whom H. pylori was eradicated. However, this introduction yielded a significant increase in IL-6 activity only in the latter group. This study indicates a dichotomy in the changes of mucosal IL-8 and IL-6 activity after H. pylori eradication. The rapid normalization of IL-8 after H. pylori eradication and the ability of H. pylori cells to stimulate IL-8 in control tissues indicate that IL-8 induction is a part of the innate (nonimmune) responses to this organism. In contrast, the results of experiments analyzing IL-6 activity in cultured mucosal tissues suggest that the gradual resolution of mucosal IL-6 activity and mononuclear infiltration after successful eradication observed in vivo may reflect gradually diminishing residual immune responses against H. pylori.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746573      PMCID: PMC108584     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production.

Authors:  P R Harris; H L Mobley; G I Perez-Perez; M J Blaser; P D Smith
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

2.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

3.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

Review 4.  The biology of interleukin-6.

Authors:  T Kishimoto
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

5.  Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis.

Authors:  T Hirano; T Matsuda; M Turner; N Miyasaka; G Buchan; B Tang; K Sato; M Shimizu; R Maini; M Feldmann
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

6.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

7.  Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. The Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities.

Authors:  D Morgan; W Kraft; M Bender; A Pearson
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

8.  Involvement of IL-6 in mesangial proliferative glomerulonephritis.

Authors:  Y Horii; A Muraguchi; M Iwano; T Matsuda; T Hirayama; H Yamada; Y Fujii; K Dohi; H Ishikawa; Y Ohmoto
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

9.  Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.

Authors:  M Seitz; B Dewald; N Gerber; M Baggiolini
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

10.  Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.

Authors:  J G Coghlan; D Gilligan; H Humphries; D McKenna; C Dooley; E Sweeney; C Keane; C O'Morain
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321

View more
  15 in total

1.  Cytokine expression and production by purified Helicobacter pylori urease in human gastric epithelial cells.

Authors:  T Tanahashi; M Kita; T Kodama; Y Yamaoka; N Sawai; T Ohno; S Mitsufuji; Y P Wei; K Kashima; J Imanishi
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization.

Authors:  Tomokazu Mizuno; Takafumi Ando; Kazuo Nobata; Tomoyuki Tsuzuki; Osamu Maeda; Osamu Watanabe; Masaaki Minami; Kenji Ina; Kazuo Kusugami; Richard M Peek; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

3.  Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells.

Authors:  In Ohk Lee; Jie Hyun Kim; Yeun Jung Choi; Michael H Pillinger; Seok-Yong Kim; Martin J Blaser; Yong Chan Lee
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

4.  A conventional beagle dog model for acute and chronic infection with Helicobacter pylori.

Authors:  G Rossi; M Rossi; C G Vitali; D Fortuna; D Burroni; L Pancotto; S Capecchi; S Sozzi; G Renzoni; G Braca; G Del Giudice; R Rappuoli; P Ghiara; E Taccini
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Anti-CagA immunoglobulin G responses correlate with interleukin-8 induction in human gastric mucosal biopsy culture.

Authors:  T Ando; G I Perez-Perez; K Kusugami; M Ohsuga; K C Bloch; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

6.  Multiple genes in the left half of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells.

Authors:  S D Li; D Kersulyte; I J Lindley; B Neelam; D E Berg; J E Crabtree
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  Molecular and histological evaluation of tumor necrosis factor-alpha expression in Helicobacter pylori-mediated gastric carcinogenesis.

Authors:  Cinghu Senthilkumar; Sivasithambaram Niranjali; Venkatraman Jayanthi; Thiyagarajan Ramesh; Halagowder Devaraj
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-29       Impact factor: 4.553

8.  Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori.

Authors:  Hong Lu; Jeng Yih Wu; Takahiko Kudo; Tomoyuki Ohno; David Y Graham; Yoshio Yamaoka
Journal:  Mol Biol Cell       Date:  2005-07-19       Impact factor: 4.138

Review 9.  Causal role of Helicobacter pylori infection in gastric cancer.

Authors:  Takafumi Ando; Yasuyuki Goto; Osamu Maeda; Osamu Watanabe; Kazuhiro Ishiguro; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

10.  Helicobacter pylori-infection-associated CpG island hypermethylation in the stomach and its possible association with polycomb repressive marks.

Authors:  Eun Joo Yoo; Seog-Yun Park; Nam-Yun Cho; Nayoung Kim; Hye Seung Lee; Gyeong Hoon Kang
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.